Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Non-University Tertiary Care Center Experience

被引：0

作者：

Darian, Sahar ^{[1
]}

Malo, Juan S. ^{[2
]}

Lim, Joseph S. ^{[2
]}

Buell, Joseph F. ^{[2
]}

Osman, Houssam ^{[2
]}

Van Meter, Travis ^{[3
]}

Jeyarajah, D. Rohan ^{[1
,2
]}

机构：

[1] Texas Christian Univ, Burnett Sch Med, Ft Worth, TX USA

[2] Methodist Richardson Med Ctr, Dept Surg, 2805 East President George Bush Highway, Richardson, TX 75082 USA

[3] MTV IR Intervent Radiol, Dallas, TX USA

来源：

SURGICAL INNOVATION | 2025年

关键词：

yttrium-90 (Y-90); intrahepatic cholangiocarcinoma; selective internal radiation therapy; METASTATIC COLORECTAL-CANCER; SURGICAL-TREATMENT; PLUS GEMCITABINE; LIVER; CISPLATIN;

D O I：

10.1177/15533506251317283

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background Intrahepatic cholangiocarcinoma (ICC) presents a significant clinical challenge due to its high fatality rate and limited surgical candidacy. With only 30-40% of patients eligible for surgery upon diagnosis, alternative therapies are imperative. This study assesses the efficacy of Yttrium-90 (Y-90) radioembolization for unresectable ICC patients in a non-university tertiary care center (NUTCC).Methods A retrospective analysis of 15 unresectable ICC patients treated with Y-90 radioembolization was conducted. Tumor response, survival, and adverse events were evaluated using RECIST criteria.Results 60% of patients exhibited partial response, and 20% showed stable disease, with notable tumor size reduction and a median survival of 14 months. Minimal adverse effects were observed, indicating Y-90's favorable safety profile.Conclusion Y-90 radioembolization shows potential in reducing tumor burden and enhancing survival rates with minimal adverse effects for unresectable ICC. Larger prospective studies are needed to confirm its efficacy and define its role in ICC treatment protocols.

引用

页码：229 / 234

页数：6

共 17 条

[1] Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Intrahepatic Cholangiocarcinoma [J].

Boehm, Lucas M. ;

Jayakrishnan, Thejus T. ;

Miura, John T. ;

Zacharias, Anthony J. ;

Johnston, Fabian M. ;

Turaga, Kiran K. ;

Gamblin, T. Clark .

JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (02) :213-220

[2] Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma [J].

Bridgewater, John ;

Galle, Peter R. ;

Khan, Shahid A. ;

Llovet, Josep M. ;

Park, Joong-Won ;

Patel, Tushar ;

Pawlik, Timothy M. ;

Gores, Gregory J. .

JOURNAL OF HEPATOLOGY, 2014, 60 (06) :1268-1289

[3] Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials [J].

Chiang, Nai-Jung ;

Chen, Li-Tzong ;

Shan, Yan-Shen ;

Yeh, Chun-Nan ;

Chen, Ming-Huang .

BIOMOLECULES, 2021, 11 (01) :1-20

[4]

Chuo FF, 1997, HEPATO-GASTROENTEROL, V44, P760

[5] Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution [J].

DeOliveira, Michelle L. ;

Cunningham, Steven C. ;

Cameron, John L. ;

Kamangar, Farin ;

Winter, Jordan M. ;

Lillemoe, Keith D. ;

Choti, Michael C. ;

Yeo, Charles J. ;

Schulick, Richard D. .

ANNALS OF SURGERY, 2007, 245 (05) :755-762

[6] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

[7] Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy [J].

Hendlisz, Alain ;

Van den Eynde, Marc ;

Peeters, Marc ;

Maleux, Geert ;

Lambert, Bieke ;

Vannoote, Jaarke ;

De Keukeleire, Katrien ;

Verslype, Chris ;

Defreyne, Luc ;

Van Cutsem, Eric ;

Delatte, Philippe ;

Delaunoit, Thierry ;

Personeni, Nicola ;

Paesmans, Marianne ;

Van Laethem, Jean-Luc ;

Flamen, Patrick .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) :3687-3694

[8] Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm [J].

Jeyarajah, D. Rohan ;

Doyle, Maria B. Majella ;

Espat, N. Joseph ;

Hansen, Paul D. ;

Iannitti, David A. ;

Kim, Joseph ;

Thambi-Pillai, Thavam ;

Visser, Brendan C. .

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (02) :443-460

[9] Cholangiocarcinoma [J].

Khan, Adeel S. ;

Dageforde, Leigh Anne .

SURGICAL CLINICS OF NORTH AMERICA, 2019, 99 (02) :315-+

[10] International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres [J].

Levillain, Hugo ;

Bagni, Oreste ;

Deroose, Christophe M. ;

Dieudonne, Arnaud ;

Gnesin, Silvano ;

Grosser, Oliver S. ;

Kappadath, S. Cheenu ;

Kennedy, Andrew ;

Kokabi, Nima ;

Liu, David M. ;

Madoff, David C. ;

Mahvash, Armeen ;

Martinez de la Cuesta, Antonio ;

Ng, David C. E. ;

Paprottka, Philipp M. ;

Pettinato, Cinzia ;

Rodriguez-Fraile, Macarena ;

Salem, Riad ;

Sangro, Bruno ;

Strigari, Lidia ;

Sze, Daniel Y. ;

de Wit van der Veen, Berlinda J. ;

Flamen, Patrick .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (05) :1570-1584

← 1 2 →